April 26, 2013
In this issue:
Attend SITC's cutting edge symposium at the AAI Annual Meeting on Saturday, May 4
"Cancer Immunotherapy 2013:
Overcoming Barriers to Adaptive Immunity"
May 4, 2013 | 9:45 am - 11:45 am | Hawaii Convention Center | Honolulu, HI
Join leaders in the cancer immunotherapy field at SITC's compelling guest-society symposium featuring updates on cancer immunotherapy in the pre-clinical/clinical setting, and translating cancer immunotherapy to clinical application. The session will focus on current strategies that can modify the adaptive immune systems, and enhance the development of therapeutically effective T cell responses, preventing tumor progression. Preclinical and clinical studies addressing the obstacles to efficacy with the goal of establishing responses that can mediate tumor eradication will also be presented.
Session topics and speakers include:
- Cancer Immunoediting: Antigens, Mechanisms and Therapeutic Implications
Robert D. Schreiber, PhD - Washington University School of Medicine - Creating High Avidity T Cells for Targeting Tumors
Philip D. Greenberg, MD - University of Washington - Innate and Adaptive Immune Regulation within the Tumor Microenvironment
Thomas F. Gajewski, MD, PhD - University of Chicago - Targeting Tumor Tissues for Improving Immune Responses by Next Generation of Antibody Treatment
Yang-Xin Fu, MD, PhD - University of Chicago - PD-1/PD-L1 Axis
Julie R. Brahmer, MD - Johns Hopkins University
Session attendees must register for the AAI Annual Meeting at: http://www.immunology2013.org/
Can’t make it to the program? Connect with SITC throughout AAI at booth 1914 (next to lounge #2).
Heading to ASCO next month? Reserve your spot for SITC's CME-Certified Program:
"Advances in Cancer Immunotherapy:
From Bench to Bedside and Back"
.jpg)
Friday, May 31, 2013 | 8:00 am - 1:00 pm | Hilton Chicago | Chicago, IL
Kick off your weekend at ASCO with SITC’s CME-certified program featuring the latest topics in cancer immunotherapy. “Advances in Cancer Immunotherapy: From Bench to Bedside and Back" is specifically designed to provide the entire unit of care involved in treating cancer patients with a foundation for understanding core immunology principles. The program will create discussion pertaining to the most recent advancements in the field of immunology and the immunotherapy of malignancy, and promote the advancement of immune-based cancer treatments to improve outcomes for patients with cancer.
This can’t miss session will feature a series of lectures by leading cancer immunologists with expertise in the clinical application of recently approved treatment options. They will discuss how to more effectively implement cancer immunotherapy treatments into clinical practice through a sound understanding of how they work, their side effects and their efficacy to improve patient outcomes.
Attendees can also take advantage of the opportunity for professional networking that will promote collaboration and scientific exchange.
Program topics and speakers include:
- Basic Immunology
Justin P. Kline, MD - University of Chicago - Tumor Microenvironment
Thomas F. Gajewski, MD, PhD - University of Chicago - Immune Potentiating Cytokines
Howard L. Kaufman, MD - Rush University Medical Center - Therapeutic Cancer Vaccines
Douglas G. McNeel, MD, PhD - University of Wisconsin - Adoptive T Cell Transfer
Patrick Hwu, MD - MD Anderson Cancer Center - Checkpoint Blockade
Julie Brahmer - Johns Hopkins University - Immune System Role For Traditional Cancer Therapies
Sandra Demaria, MD - New York University School of Medicine
Program organizers:
Thomas F. Gajewski, MD, PhD - University of Chicago
Justin P. Kline, MD - University of Chicago
|
Registration is limited and early registration rates are still available! For full accreditation information and to register, visit: www.sitcancer.org/sitc-meetings/aci2013/aci13-il/registration. |
Won’t be at ASCO? SITC is bringing the “Advances in Cancer Immunotherapy: From Bench to Bedside and Back” program to an area near you. New updates are being made weekly, so please visit: www.sitcancer.org/sitc-meetings/aci2013 for more information.
Jointly sponsored by:
 |
.jpg) |
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and the Society of Immunotherapy of Cancer. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Postgraduate Institute for Medicine designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Full disclosure of support will be made in course materials.
Submit your research to the Journal for ImmunoTherapy of Cancer, the official journal of SITC! The Society is pleased to offer SITC members waived article processing charges for manuscripts accepted through 2013. For more information, visit: http://www.sitcancer.org/journal
.gif){kind=small} |
Now accepting submissions in: |
